High Risk Human Papillomavirus

High Risk Human Papillomavirus (HPV) refers to a group of viruses that can lead to certain types of cancer, primarily cervical cancer, but also others such as anal, oropharyngeal, vaginal, vulvar, and penile cancers. Understanding this common sexually transmitted infection is crucial for public health and individual well-being.

High Risk Human Papillomavirus

Key Takeaways

  • High Risk Human Papillomavirus is a common sexually transmitted infection linked to several cancers.
  • Most high-risk HPV infections are asymptomatic and resolve on their own, but persistent infections can lead to precancerous changes.
  • The primary cause of high-risk HPV infection is sexual contact.
  • Vaccination and regular screening (like Pap tests) are vital tools for prevention and early detection of HPV-related cancers.
  • Globally, HPV types 16 and 18 are responsible for the majority of HPV-related cancers.

What is High Risk Human Papillomavirus (HPV)?

High Risk Human Papillomavirus (HPV) is a classification of specific HPV types known for their potential to cause cellular changes that can lead to cancer. Unlike low-risk HPV types, which typically cause benign conditions like genital warts, high-risk types integrate their DNA into host cells, potentially disrupting normal cell growth and leading to precancerous lesions and, if left untreated, invasive cancer. The most common high-risk types are HPV 16 and HPV 18, which together account for approximately 70% of all cervical cancers globally, according to the World Health Organization (WHO).

Information on high risk human papillomavirus highlights that while many people will contract HPV at some point in their lives, most infections are transient and cleared by the immune system without causing any health problems. However, persistent infection with a high-risk HPV type is a necessary step for the development of HPV-related cancers. Regular screening and vaccination efforts aim to prevent these persistent infections and detect precancerous changes early.

High Risk HPV Symptoms and Causes

Most infections with high risk HPV are asymptomatic, meaning individuals often do not experience any noticeable symptoms. This lack of initial symptoms is a key reason why the virus can spread unknowingly and why regular screening is so important. Symptoms typically only manifest if the infection persists and leads to the development of precancerous lesions or cancer itself. These symptoms vary depending on the affected area of the body.

Potential symptoms associated with HPV-related cancers can include:

  • Cervical Cancer: Abnormal vaginal bleeding (after sex, between periods, or post-menopause), unusual vaginal discharge, pelvic pain.
  • Anal Cancer: Anal itching, pain, bleeding, or a lump in the anal area.
  • Oropharyngeal Cancer: Persistent sore throat, earache, difficulty swallowing, a lump in the neck, or voice changes.
  • Vulvar Cancer: Itching, pain, tenderness, or a lump in the vulvar area.
  • Vaginal Cancer: Abnormal vaginal bleeding, pain during intercourse, or a vaginal lump.
  • Penile Cancer: Changes in skin color, thickening of the skin, or a sore on the penis.

The primary cause of high-risk HPV infection is sexual contact. The virus is transmitted through skin-to-skin contact, typically during vaginal, anal, or oral sex. It can be transmitted even when an infected person has no visible signs or symptoms. Understanding high risk HPV transmission is crucial for prevention, as condoms do not offer complete protection because the virus can infect areas not covered by a condom. Risk factors for acquiring high-risk HPV include having multiple sexual partners, early age of sexual debut, and a weakened immune system. The Centers for Disease Control and Prevention (CDC) states that nearly all sexually active men and women will get HPV at some point in their lives if they don’t get the HPV vaccine.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.